• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酰胺酯前药技术在 5'-mRNA 帽类似物中环外氨基修饰合成中的应用。

Application of Phosphoramidate ProTide Technology for the Synthesis of 5'-mRNA Cap Analogs Modified on the Exocyclic Amine Group.

机构信息

Faculty of Chemistry, University of Warsaw, 1 Pasteur St., 02-093, Warsaw, Poland.

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-089, Warsaw, Poland.

出版信息

ChemMedChem. 2023 Feb 14;18(4):e202200490. doi: 10.1002/cmdc.202200490. Epub 2023 Jan 19.

DOI:10.1002/cmdc.202200490
PMID:36658701
Abstract

Aryloxy triester phosphoramidate methodology, commonly known as ProTide technology, is one of the most widely used prodrug approaches applied to therapeutic nucleosides. This approach has been used extensively by the pharmaceutical industry and researchers in medicinal chemistry. Herein we report our adaptation of this effective method for the synthesis of bioactive 5'-mRNA cap analogues as inhibitors for targeting cap-dependent translation. The synthesis was performed in two main stages: preparation of N2-modified guanosine analogues and their subsequent transformation into prodrugs using phenylethoxy-l-alaninyl phosphorochloridate. The prepared pro-nucleotide cap analogues were tested for their capacity in enzymatic activation, inhibitory properties in a rabbit reticulocyte lysate system, and passive membrane translocation properties.

摘要

芳氧基三酯磷酰胺方法,通常称为 ProTide 技术,是应用于治疗性核苷的最广泛使用的前药方法之一。该方法已被制药行业和药物化学研究人员广泛使用。在此,我们报告了我们对这种有效方法的适应,用于合成作为针对帽依赖性翻译的靶标的生物活性 5'-mRNA 帽类似物。合成分两个主要阶段进行:制备 N2-修饰的鸟苷类似物及其随后使用苯乙氧基-l-丙氨酰基磷酰氯转化为前药。测试了制备的前核苷酸帽类似物在酶激活中的能力、在兔网织红细胞裂解物系统中的抑制特性以及被动膜转位特性。

相似文献

1
Application of Phosphoramidate ProTide Technology for the Synthesis of 5'-mRNA Cap Analogs Modified on the Exocyclic Amine Group.磷酰胺酯前药技术在 5'-mRNA 帽类似物中环外氨基修饰合成中的应用。
ChemMedChem. 2023 Feb 14;18(4):e202200490. doi: 10.1002/cmdc.202200490. Epub 2023 Jan 19.
2
Synthesis of phosphoramidate prodrugs: ProTide approach.磷酰胺酯前药的合成:ProTide方法。
Curr Protoc Nucleic Acid Chem. 2013 Jun;Chapter 15:15.5.1-15.5.15. doi: 10.1002/0471142700.nc1505s53.
3
Synthesis and anti-herpetic activity of phosphoramidate ProTides.磷酰胺酯 ProTides 的合成及抗疱疹活性。
ChemMedChem. 2013 Jun;8(6):985-93. doi: 10.1002/cmdc.201300035. Epub 2013 Apr 18.
4
An overview of ProTide technology and its implications to drug discovery.ProTide 技术概述及其对药物发现的影响。
Expert Opin Drug Discov. 2021 Oct;16(10):1149-1161. doi: 10.1080/17460441.2021.1922385. Epub 2021 May 24.
5
Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.芳氧基磷酰胺酸酯三酯:将单磷酸化核苷和糖递送到细胞内的技术。
ChemMedChem. 2009 Nov;4(11):1779-91. doi: 10.1002/cmdc.200900289.
6
Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.磷酰胺酯前药技术的应用显著提高了碳环腺苷衍生物的抗病毒效力。
J Med Chem. 2006 Nov 30;49(24):7215-26. doi: 10.1021/jm060776w.
7
New Heights for ProTides?普瑞替啶再创佳绩?
J Med Chem. 2021 Nov 25;64(22):16422-16424. doi: 10.1021/acs.jmedchem.1c01908. Epub 2021 Nov 16.
8
N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA.N2 修饰的帽类似物作为翻译抑制剂和治疗性 mRNA 制备的底物。
Eur Biophys J. 2023 Oct;52(6-7):511-519. doi: 10.1007/s00249-023-01676-7. Epub 2023 Sep 1.
9
The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).磷酰胺酯前药技术在强效抗丙型肝炎病毒化合物4'-叠氮胞苷(R1479)中的应用。
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4250-4. doi: 10.1016/j.bmcl.2009.05.099. Epub 2009 May 29.
10
Modified ARCA analogs providing enhanced translational properties of capped mRNAs.修饰的 ARCA 类似物提供了增强 capped mRNAs 翻译性质的特性。
Cell Cycle. 2018;17(13):1624-1636. doi: 10.1080/15384101.2018.1486164. Epub 2018 Aug 17.

引用本文的文献

1
The Synergistic Effect of N2 and N7 Modifications on the Inhibitory Efficacy of mRNA Cap Analogues.N2和N7修饰对mRNA帽类似物抑制功效的协同作用。
Pharmaceuticals (Basel). 2024 May 14;17(5):632. doi: 10.3390/ph17050632.